Logo image of COV.CA

COVALON TECHNOLOGIES LTD (COV.CA) Stock Analyst Earnings Estimates

TSX-V:COV - TSX Venture Exchange - CA22282D3022 - Common Stock - Currency: CAD

2.8  -0.38 (-11.95%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
COV.CA revenue by date.COV.CA revenue by date.
18.146M
-7.23%
26.595M
46.56%
31.169M
17.20%
36.982M
18.65%
40.838M
10.43%
44.69M
9.43%
48.376M
8.25%
52.799M
9.14%
57.928M
9.71%
EBITDA
YoY % growth
COV.CA ebitda by date.COV.CA ebitda by date.
-8.11M
-1,200.36%
-3.559M
56.11%
3.137M
188.15%
2.966M
-5.47%
4.073M
37.32%
5.513M
35.35%
6.775M
22.89%
8.442M
24.61%
10.417M
23.39%
EBIT
YoY % growth
COV.CA ebit by date.COV.CA ebit by date.
-9.142M
-25,133.76%
-4.529M
50.47%
2.151M
147.50%
1.332M
-38.08%
3.228M
142.34%
5.114M
58.43%
6.836M
33.67%
9.045M
32.31%
11.67M
29.02%
Operating Margin
COV.CA operating margin by date.COV.CA operating margin by date.
-50.38%-17.03%6.90%3.60%7.90%11.44%14.13%17.13%20.15%
EPS
YoY % growth
COV.CA eps by date.COV.CA eps by date.
N/AN/AN/A0.04
-69.23%
0.07
75.00%
0.12
71.43%
0.17
33.67%
0.22
31.23%
0.29
33.35%

All data in CAD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth
0.03
-43.47%
0.07
32.53%
-0.04
-306.00%
Revenue
Q2Q % growth
9.27M
9.06%
10.3M
12.36%
10.3M
16.15%
EBITDA
Q2Q % growth
1.382M
-29.87%
2.493M
12.82%
-586.07K
-135.50%
EBIT
Q2Q % growth
980.56K
-33.87%
2.091M
41.72%
-987.77K
-248.68%

All data in CAD

Recent Earnings VS Estimates Surprises (CAD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth
0.04 -0.030.07237.83%
Q4 2024
Q2Q % growth
0.02 0.05-0.03-61.17%
Q3 2019
Q2Q % growth
-0.16 -0.02-0.14-676.70%
COV.CA Yearly EPS VS EstimatesCOV.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.05 0.1 0.15 0.2 0.25
Recent Revenue VS Estimates Surprises (CAD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth
8.291M
77.80%
6.18M2.111M34.16%
Q4 2024
Q2Q % growth
8.868M
28.61%
10.117M-1.249M-12.35%
Q3 2024
Q2Q % growth
9.167M
46.20%
%
Q2 2024
Q2Q % growth
8.5M
17.32%
%
Q1 2024
Q2Q % growth
4.663M
-24.61%
%
Q4 2023
Q2Q % growth
6.895M
27.92%
%
Q3 2023
Q2Q % growth
6.27M
38.53%
%
Q2 2023
Q2Q % growth
7.245M
119.94%
%
Q1 2023
Q2Q % growth
6.185M
25.30%
%
Q4 2022
Q2Q % growth
5.39M
-72.44%
%
Q3 2022
Q2Q % growth
4.526M
-48.66%
%
Q2 2022
Q2Q % growth
3.294M
-51.14%
%
Q1 2022
Q2Q % growth
4.936M
89.88%
%
Q4 2021
Q2Q % growth
19.561M
44.81%
%
Q3 2021
Q2Q % growth
8.816M
32.10%
%
Q2 2021
Q2Q % growth
6.741M
28.20%
%
Q1 2021
Q2Q % growth
2.6M
-67.29%
%
Q4 2020
Q2Q % growth
13.508M
105.40%
%
Q3 2020
Q2Q % growth
6.673M
-2.63%
%
Q2 2020
Q2Q % growth
5.259M
-60.50%
%
Q1 2020
Q2Q % growth
7.949M
9.46%
%
Q3 2019
Q2Q % growth
6.854M 7.313M-459.01K-6.28%
Q2 2019
Q2Q % growth
13.313M 7.313M6M82.04%
COV.CA Yearly Revenue VS EstimatesCOV.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10M 20M 30M 40M 50M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A -0.99% N/A
RevenueN/A N/A 0% N/A